FDA Faulted For Lapses In Orphan Drug Program

FDA Faulted For Lapses In Orphan Drug Program

Source: 
NPR
snippet: 

The Food and Drug Administration has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials said in a report Friday.